The tweet was deleted by the author.
But we saved everything 🙂.
Phathom Pharmaceuticals announced plans to participate in several investor conferences throughout May and June. The company invited investors to tune in for the latest updates via virtual and in-person events.
These conference appearances offer Phathom Pharmaceuticals an opportunity to communicate its financial outlook and strategic direction directly to the investment community. Details on the specific conferences and presentation content were not disclosed. Investors are encouraged to follow the company’s official channels for access to live streams and further announcements.
Phathom previously announced a live session at DDW2026 to present new clinical efficacy and safety data for VOQUEZNA, its lead therapy candidate, according to company statements. The firm also confirmed team attendance and booth activity at the DDW2026 event in Chicago, inviting the gastroenterology community to connect at booth 2511 at the upcoming conference. These appearances form part of Phathom’s ongoing outreach to investors and the medical community.